Patients with HPV-positive oropharyngeal cancer may not require post-radiation surgery
the ONA take:
According to new findings presented at the American Society for Radiation Oncology's (ASTRO) 56th Annual Meeting in San Francisco, California, patients with human papillomavirus (HPV)-positive oropharyngeal cancer may not require neck surgery after receiving radiation therapy and chemotherapy.
In the study, researchers at Fox Chase Cancer Center in Philadelphia, Pennsylvania, analyzed the medical records of 396 patients with at least locally advanced oropharyngeal cancer. Of those, the records of 99 patients indicated whether or not their cancer had likely been activated by HPV, and 146 patients underwent neck surgery within 180 days after the completion of radiation therapy.
The researchers found that patients with HPV-positive oropharygneal cancer were most likely to respond better to treatment compared with those with HPV-negative cancer. This trend has also been seen in previous studies. Patients who were found to have a protein called p16, an indicator of HPV-positive cancer, were less likely to experience a recurrence of their cancer.
Patients with HPV-positive cancer who elected to undergo neck surgery were more likely to have benign bumps, while those uninfected by HPV who underwent neck surgery were more likely to have malignant bumps.
HPV-positive oropharyngeal cancer may not require surgery after receiving radiation and chemo.
A new study shows that patients with human papillomavirus (HPV) – the same virus associated with both cervical and head and neck cancer – positive oropharyngeal cancer see significantly higher rates of complete response on a post-radiation neck dissection than those with HPV-negative oropharyngeal cancer.
Fox Chase Cancer Center researchers presented the findings at the American Society for Radiation Oncology's 56th Annual Meeting on Wednesday, September 17.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|